MedTrace Logo

Biomarkers of Diabetic Retinopathy Progression

NCT01607190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-07-19

No results posted yet for this study

Summary

The purpose of this study is to validate a predictive model of diabetic retinopathy progression in patients with diabetes mellitus type 2 patients to clinically significant macular edema (CSME) needing treatment either photocoagulation or intravitreal injections (ITV) using non-invasive techniques.

Conditions

Sponsors & Collaborators

  • Association for Innovation and Biomedical Research on Light and Image

    lead OTHER

Principal Investigators

  • José Cunha-Vaz, MD, PhD · Association for Innovation and Biomedical Research on Light and Image

Eligibility

Min Age
35 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2016-04-30
Completion
2017-12-31

Countries

  • India
  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01607190 on ClinicalTrials.gov